These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28884752)

  • 1. Alzheimer disease: Revising the risk of Alzheimer disease in women.
    Patel M
    Nat Rev Neurol; 2017 Oct; 13(10):575. PubMed ID: 28884752
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Czech C; Mönning V; Tienari PJ; Hartmann T; Masters C; Beyreuther K; Förstl H
    Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901624
    [No Abstract]   [Full Text] [Related]  

  • 3. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Roses AD; Pericak-Vance MA; Small GW; Haines JL
    JAMA; 1995 Feb; 273(5):373-4. PubMed ID: 7823376
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein E ε4 and Risk Factors for Alzheimer Disease-Let's Talk About Sex.
    Dubal DB; Rogine C
    JAMA Neurol; 2017 Oct; 74(10):1167-1168. PubMed ID: 28846761
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoprotein E and Alzheimer disease.
    Growdon JH
    Arch Neurol; 1998 Aug; 55(8):1053-4. PubMed ID: 9708953
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.
    West HL; Rebeck GW; Hyman BT
    Neurosci Lett; 1994 Jul; 175(1-2):46-8. PubMed ID: 7970208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.
    Tsuboi Y; Josephs KA; Cookson N; Dickson DW
    Neurology; 2003 Jan; 60(2):240-5. PubMed ID: 12552038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summaries for patients. Genes and Alzheimer disease.
    Ann Intern Med; 2002 Aug; 137(3):I-18. PubMed ID: 12160384
    [No Abstract]   [Full Text] [Related]  

  • 9. Apolipoprotein E genotype and the rate of decline in probable Alzheimer disease.
    Corder EH; Lannfelt L; Basun H
    Arch Neurol; 1996 Nov; 53(11):1094-5. PubMed ID: 8912482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apolipoprotein E and Alzheimer disease].
    Berr C
    Rev Neurol (Paris); 1995 Jan; 151(1):3-5. PubMed ID: 7676127
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection against Alzheimer's disease with apoE epsilon 2.
    Talbot C; Lendon C; Craddock N; Shears S; Morris JC; Goate A
    Lancet; 1994 Jun; 343(8910):1432-3. PubMed ID: 7910910
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Anwar N; Lovestone S; Cheetham ME; Levy R; Powell JF
    Lancet; 1993 Nov; 342(8882):1308-9. PubMed ID: 7901622
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal MR imaging in Alzheimer disease: a study anyone can join.
    Bizzi A
    Radiology; 2011 Mar; 258(3):657-9. PubMed ID: 21339344
    [No Abstract]   [Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.
    Kivipelto M; Helkala EL; Laakso MP; Hänninen T; Hallikainen M; Alhainen K; Iivonen S; Mannermaa A; Tuomilehto J; Nissinen A; Soininen H
    Ann Intern Med; 2002 Aug; 137(3):149-55. PubMed ID: 12160362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease.
    Corder EH; Saunders AM; Pericak-Vance MA; Roses AD
    Arch Neurol; 1995 Jul; 52(7):650-1. PubMed ID: 7619017
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic factors in Alzheimer's disease.
    Bird TD
    N Engl J Med; 2005 Mar; 352(9):862-4. PubMed ID: 15745976
    [No Abstract]   [Full Text] [Related]  

  • 17. APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease.
    Meyer MR; Tschanz JT; Norton MC; Welsh-Bohmer KA; Steffens DC; Wyse BW; Breitner JC
    Nat Genet; 1998 Aug; 19(4):321-2. PubMed ID: 9697689
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer Research Forum Live Discussion: sports concussions, dementia, and ApoE genotyping: what can scientists tell the public? What's up for research?
    J Alzheimers Dis; 2009; 16(3):657-66. PubMed ID: 19276560
    [No Abstract]   [Full Text] [Related]  

  • 19. Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study.
    Rusanen M; Rovio S; Ngandu T; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
    Dement Geriatr Cogn Disord; 2010; 30(3):277-84. PubMed ID: 20847559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon2 does not increase risk of early-onset sporadic Alzheimer's disease.
    Scott WK; Saunders AM; Gaskell PC; Locke PA; Growdon JH; Farrer LA; Auerbach SA; Roses AD; Haines JL; Pericak-Vance MA
    Ann Neurol; 1997 Sep; 42(3):376-8. PubMed ID: 9307262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.